CRDF
Cardiff OncologyANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
9
U.S. public peers
Grade Position
Above peers
vs peer average
CRDF vs peer average
91/100
CRDF vs. peer average (A vs. D)
Grade spread
A 1 · B 1 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CING is the first available peer comparator.
Same-sector market-cap screening comparator only; the packet does not validate direct overlap with Cardiff's RAS-mutated mCRC indication, onvansertib mechanism, or development stage. Not used for relative valuation.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CRDF
Cardiff Oncology
CING
Cingulate
Grade
A
C
Momentum
91
12
Value
41
41
Sentiment
65
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs CING
CRDF / CING
Grade Position
Above peers
CRDF vs. peer average (A vs. D)
91/100
Momentum
91
CRDFValue
41
CRDFSentiment
65
CINGRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CRDF
CING is the first peer returned for this comparison set.